| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/XueYSCWC04 |
| P356 | DOI | 10.1021/CI049971E |
| P698 | PubMed publication ID | 15272858 |
| P5875 | ResearchGate publication ID | 8436573 |
| P50 | author | Chun Wei Yap | Q57056600 |
| Ying Xue | Q42837170 | ||
| P2093 | author name string | Chen YZ | |
| Cao ZW | |||
| Wang JF | |||
| Sun LZ | |||
| P2860 | cites work | A general pattern for substrate recognition by P‐glycoprotein | Q54145580 |
| Gene Selection for Cancer Classification using Support Vector Machines | Q56535529 | ||
| Wrappers for feature subset selection | Q56689295 | ||
| Probabilistic neural networks | Q56764134 | ||
| Choosing Multiple Parameters for Support Vector Machines | Q56906379 | ||
| VolSurf: a new tool for the pharmacokinetic optimization of lead compounds | Q56979325 | ||
| Handbook of Molecular Descriptors | Q62968825 | ||
| Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents | Q73626792 | ||
| Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity | Q73705879 | ||
| Quantum-Chemical Descriptors in QSAR/QSPR Studies | Q77646254 | ||
| Structure and mechanism of ABC transporters | Q78725214 | ||
| Knowledge-based analysis of microarray gene expression data by using support vector machines | Q27939386 | ||
| Assessing the accuracy of prediction algorithms for classification: an overview | Q29615358 | ||
| Drug design by machine learning: support vector machines for pharmaceutical data analysis | Q30668015 | ||
| An accelerated procedure for recursive feature ranking on microarray data. | Q30810344 | ||
| Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis | Q30966916 | ||
| Support vector machine classification and validation of cancer tissue samples using microarray expression data | Q31835844 | ||
| Biochemical, cellular, and pharmacological aspects of the multidrug transporter | Q33636699 | ||
| Structure and function of multidrug transporters. | Q33767171 | ||
| The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors | Q34065800 | ||
| Screening with tumor markers: critical issues | Q34551044 | ||
| Feature subset selection for splice site prediction | Q34973905 | ||
| SVM-Prot: Web-based support vector machine software for functional classification of a protein from its primary sequence | Q35208363 | ||
| Predicting protein--protein interactions from primary structure | Q40710149 | ||
| P-glycoprotein and multidrug resistance | Q41239416 | ||
| Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein | Q42015740 | ||
| A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein | Q43963966 | ||
| Prediction of torsade-causing potential of drugs by support vector machine approach. | Q44771784 | ||
| Multi-class protein fold recognition using support vector machines and neural networks | Q48681384 | ||
| Molecular Diversity and Representativity in Chemical Databases | Q50695147 | ||
| Traditional topological indices vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research | Q51652447 | ||
| Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature | Q52013462 | ||
| Support Vector Machines for predicting HIV protease cleavage sites in protein | Q52043614 | ||
| Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics | Q54049500 | ||
| P4510 | describes a project that uses | support vector machine | Q282453 |
| P433 | issue | 4 | |
| P921 | main subject | support vector machine | Q282453 |
| P304 | page(s) | 1497-1505 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Journal of Chemical Information and Computer Sciences | Q104614957 |
| P1476 | title | Prediction of P-glycoprotein substrates by a support vector machine approach | |
| P478 | volume | 44 |
| Q90877588 | A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking |
| Q130067458 | A novel adaptive ensemble classification framework for ADME prediction |
| Q46436439 | A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. |
| Q47583176 | A prediction model of drug-induced ototoxicity developed by an optimal support vector machine (SVM) method |
| Q45961509 | A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method |
| Q51901134 | A self-organizing algorithm for molecular alignment and pharmacophore development |
| Q33316422 | A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor |
| Q82353209 | A topological substructural approach for the prediction of P-glycoprotein substrates |
| Q44466600 | ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates |
| Q39138765 | Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen |
| Q37239548 | Advances in machine learning prediction of toxicological properties and adverse drug reactions of pharmaceutical agents |
| Q28740368 | Amino Acid Features of P1B-ATPase Heavy Metal Transporters Enabling Small Numbers of Organisms to Cope with Heavy Metal Pollution |
| Q38559178 | Application of Multivariate Linear and Nonlinear Calibration and Classification Methods in Drug Design |
| Q40296339 | Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors. |
| Q47813562 | Are herb-pairs of traditional Chinese medicine distinguishable from others? Pattern analysis and artificial intelligence classification study of traditionally defined herbal properties |
| Q82277218 | Automated QSPR through Competitive Workflow |
| Q58114855 | Boosted feature selectors: a case study on prediction P-gp inhibitors and substrates |
| Q37993906 | CNS drug development - lost in translation? |
| Q35986402 | Cell permeability beyond the rule of 5. |
| Q52009502 | Classification of a diverse set of Tetrahymena pyriformis toxicity chemical compounds from molecular descriptors by statistical learning methods |
| Q46775947 | Classification structure-activity relationship (CSAR) studies for prediction of genotoxicity of thiophene derivatives |
| Q34069310 | Combinatorial support vector machines approach for virtual screening of selective multi-target serotonin reuptake inhibitors from large compound libraries |
| Q37481572 | Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries |
| Q51932185 | Comparison of methods for chemical-compound affinity prediction |
| Q92576910 | Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions |
| Q51006060 | Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein. |
| Q33236244 | Computational methods in developing quantitative structure-activity relationships (QSAR): a review |
| Q48547412 | Computational models for identifying potential P-glycoprotein substrates and inhibitors |
| Q38081483 | Computational models for predicting interactions with membrane transporters. |
| Q37961443 | Computational models for predicting substrates or inhibitors of P-glycoprotein |
| Q37135905 | Computational models for prediction of interactions with ABC-transporters |
| Q33530647 | Consensus model for identification of novel PI3K inhibitors in large chemical library |
| Q37198661 | Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction |
| Q34485998 | Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries |
| Q92748223 | Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein |
| Q39709794 | Development of a Support Vector Machine-Based System to Predict Whether a Compound Is a Substrate of a Given Drug Transporter Using Its Chemical Structure |
| Q33288402 | Development of an in silico model for predicting efflux substrates in Caco-2 cells |
| Q81961796 | Development of predictive in silico model for cyclosporine- and aureobasidin-based P-glycoprotein inhibitors employing receptor surface analysis |
| Q36229209 | Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach |
| Q37863645 | Diverse approaches for the enhancement of oral drug bioavailability |
| Q51963838 | Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. |
| Q39555409 | Ensemble Rule-Based Classification of Substrates of the Human ABC-Transporter ABCB1 Using Simple Physicochemical Descriptors |
| Q46366065 | Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds. |
| Q108527466 | Feature importance sampling-based adaptive random forest as a useful tool to screen underlying lead compounds |
| Q42326093 | Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors |
| Q39766645 | Homology modeling and binding site assessment of the human P-glycoprotein |
| Q40954635 | Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer |
| Q33720954 | Hybrid scoring and classification approaches to predict human pregnane X receptor activators |
| Q33476954 | Identification of small molecule aggregators from large compound libraries by support vector machines |
| Q62664551 | Identification of vasodilators from molecular descriptors by machine learning methods |
| Q47280941 | Identifying P-glycoprotein substrates using a support vector machine optimized by a particle swarm |
| Q62664575 | Identifying hERG Potassium Channel Inhibitors by Machine Learning Methods |
| Q56984194 | In Silico ADME/Tox Predictions |
| Q56992326 | In Silico Prediction Models for Blood-Brain Barrier Permeation |
| Q45963383 | In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods. |
| Q30561373 | In silico prediction of adverse drug reactions and toxicities based on structural, biological and clinical data |
| Q45965749 | In silico prediction of pregnane X receptor activators by machine learning approaches. |
| Q45959612 | In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method. |
| Q33898229 | In silico, in vitro and in situ models to assess interplay between CYP3A and P-gp |
| Q56992289 | In silicoprediction of substrate properties for ABC-multidrug transporters |
| Q33437761 | In vivo, in vitro and in silico methods for small molecule transfer across the BBB. |
| Q44677946 | Integration of in Silico and in Vitro Tools for Scaffold Optimization during Drug Discovery: Predicting P-Glycoprotein Efflux |
| Q40572071 | Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates |
| Q51932376 | MODEL-molecular descriptor lab: a web-based server for computing structural and physicochemical features of compounds |
| Q92543197 | Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors |
| Q36929854 | Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins |
| Q62664494 | Modeling, predicting and virtual screening of selective inhibitors of MMP-3 and MMP-9 over MMP-1 using random forest classification |
| Q50876954 | Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein |
| Q115741790 | Multivariate statistical analysis methods in QSAR |
| Q33577354 | New predictive models for blood-brain barrier permeability of drug-like molecules |
| Q37725040 | Non-linear modeling and chemical interpretation with aid of support vector machine and regression |
| Q36473975 | P-glycoprotein recognition of substrates and circumvention through rational drug design |
| Q33908941 | P-glycoprotein substrate models using support vector machines based on a comprehensive data set. |
| Q36094830 | Physicochemical Profiles of the Marketed Agrochemicals and Clues for Agrochemical Lead Discovery and Screening Library Development |
| Q28477346 | Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein |
| Q91389586 | Predicting Thermodynamic Properties of Alkanes by High-Throughput Force Field Simulation and Machine Learning |
| Q45929007 | Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors. |
| Q37638515 | Predicting ligand interactions with ABC transporters in ADME. |
| Q34668324 | Predicting substrates of the human breast cancer resistance protein using a support vector machine method |
| Q37610142 | Predicting the clinical relevance of drug interactions from pre-approval studies. |
| Q51505434 | Prediction and characterization of P-glycoprotein substrates potentially bound to different sites by emerging chemical pattern and hierarchical cluster analysis |
| Q45963190 | Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods. |
| Q45964288 | Prediction of antibacterial compounds by machine learning approaches. |
| Q39990019 | Prediction of chemical carcinogenicity by machine learning approaches |
| Q36448801 | Prediction of compounds with specific pharmacodynamic, pharmacokinetic or toxicological property by statistical learning methods. |
| Q51968283 | Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and substrates by using support vector machines |
| Q40348573 | Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. |
| Q45965422 | Prediction of factor Xa inhibitors by machine learning methods. |
| Q37462980 | Prediction of functional class of proteins and peptides irrespective of sequence homology by support vector machines |
| Q28180947 | Prediction of genotoxicity of chemical compounds by statistical learning methods |
| Q90560167 | Prediction of matrix metal proteinases-12 inhibitors by machine learning approaches |
| Q45963486 | Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approaches. |
| Q38869742 | Predictors of Ulnar Collateral Ligament Reconstruction in Major League Baseball Pitchers |
| Q30561069 | QSAR Models for P-Glycoprotein Transport Based on a Highly Consistent Data Set |
| Q37365827 | QSAR analysis and molecular modeling of ABCG2-specific inhibitors |
| Q39535548 | QSAR and Predictors of Eye and Skin Effects. |
| Q38010255 | QSPR in Oral Bioavailability: Specificity or Integrality? |
| Q39896264 | Qualitative prediction of blood-brain barrier permeability on a large and refined dataset |
| Q38445592 | Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods |
| Q82712975 | Quantitative structure-toxicity relationships (QSTRs): a comparative study of various non linear methods. General regression neural network, radial basis function neural network and support vector machine in predicting toxicity of nitro- and cyano- |
| Q36393477 | Recent advances in molecular modeling and medicinal chemistry aspects of phospho-glycoprotein |
| Q36439180 | Recent progress in the computational prediction of aqueous solubility and absorption |
| Q36515046 | Recent progresses in the application of machine learning approach for predicting protein functional class independent of sequence similarity |
| Q38513539 | Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools. |
| Q33415613 | SVM model for virtual screening of Lck inhibitors |
| Q33277897 | Self-organizing maps for identification of new inhibitors of P-glycoprotein |
| Q21563489 | Semantic Similarity for Automatic Classification of Chemical Compounds |
| Q37377888 | Shape signatures: new descriptors for predicting cardiotoxicity in silico |
| Q56992331 | Similarity-Based Descriptors (SIBAR) as Tool for QSAR Studies on P-Glycoprotein Inhibitors: Influence of the Reference Set |
| Q33522294 | Solubility and permeability measurement and applications in drug discovery |
| Q62664606 | Statistical learning approach for predicting specific pharmacodynamic, pharmacokinetic, or toxicological properties of pharmaceutical agents |
| Q33636032 | Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach. |
| Q37481589 | Structure-based drug screening and ligand-based drug screening with machine learning. |
| Q47200886 | Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors |
| Q48465967 | Systems pharmacology in drug discovery and therapeutic insight for herbal medicines |
| Q38823933 | The Next Era: Deep Learning in Pharmaceutical Research |
| Q90420762 | Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme |
| Q50976814 | Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks |
| Q51853312 | Three-class classification models of logS and logP derived by using GA-CG-SVM approach |
| Q51637459 | Toward better QSAR/QSPR modeling: simultaneous outlier detection and variable selection using distribution of model features |
| Q57684264 | Transporters in Drug Discovery |
| Q39722405 | Use of shape similarities for the classification of P-glycoprotein substrates and nonsubstrates |
| Q46559332 | Using Kernel Alignment to Select Features of Molecular Descriptors in a QSAR Study |
| Q27144456 | Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties |
| Q33494643 | Virtual screening of Abl inhibitors from large compound libraries by support vector machines |
| Q48063468 | Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines |
Search more.